Hyperlipidemia in racial/ethnic minorities: Differences in lipid profiles and the impact of statin therapy

Clinical Lipidology

Volumn 4, Issue 6, 2009, Pages 741-754

  Morris, Alanna ^a   Ferdinand, Keith C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lipid; Metabolic syndrome; Pharmacogenetics; Race ethnicity; Statin

Indexed keywords

AMLODIPINE PLUS ATORVASTATIN; ATORVASTATIN; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; DYSLIPIDEMIA; ETHNIC DIFFERENCE; ETHNIC GROUP; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIA; LIFESTYLE MODIFICATION; LIPID ANALYSIS; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; MINORITY GROUP; MORBIDITY; MORTALITY; MYOPATHY; PATIENT COMPLIANCE; PHARMACOGENETICS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SIDE EFFECT;

EID: 77649089072     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.09.70     Document Type: Review

References (121)

1. Lloyd-Jones D, Adams R, Carnethon M et al.: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3), E21-E181 (2009).
2. Hozawa A, Folsom AR, Sharrett AR, Chambless LE: Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of african American with white subjects- Atherosclerosis Risk in Communities Study. Arch. Intern. Med. 167(6), 573-579 (2007).
3. Centers for Disease Control and Prevention: Differences in prevalence of obesity among black, white, and Hispanic adults-United States, 2006-2008. MMWR 58(27), 740-744 (2009).
4. D'Agostino SRB, Grundy S, Sullivan LM, Wilson P; for the CHDRPG: Validation of the Framingham Coronary Heart Disease Prediction Scores: results of a multiple ethnic groups investigation. JAMA 286(2), 180-187 (2001).
5. Sundquist J, Winkleby MA: Cardiovascular risk factors in mexican american adults: a transcultural analysis of NHANES III, 1988-1994. Am. J. Public Health 89(5), 723-730 (1999).
6. Cooper R, Cutler J, Desvigne-Nickens P et al.: trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the National Conference on Cardiovascular Disease Prevention. Circulation 102(25), 3137-3147 (2000).
7. Lee ET, Cowan LD, Welty TK et al.: All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988: The Strong Heart Study. Am. J. Epidemiol. 147(11), 995-1008 (1998).
8. National Center for Health Statistics: Health, United States 2007. With chartbook on trends in the health of Americans. Hyattsville, MD, USA. National Center for Health Statistics, Washington, DC, USA (2007).
9. Anand SS, Yusuf S, Vuksan V et al.: Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356(9226), 279 (2000).
10. Joshi P, Islam S, Pais P et al.: Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 297(3), 286-294 (2007).
11. Gunarathne A, Patel JV, Gammon B, Hughes EA, Lip GYH: Impact of mean arterial blood pressure on higher arterial stiffness indices in South Asians compared to white Europeans. J. Hypertens. 26(7), 1420-1426 (2008).
12. Lyratzopoulos G, McElduff P, Heller R, Hanily M, Lewis P: Comparative levels and time trends in blood pressure, total cholesterol, body mass index and smoking among Caucasian and South-Asian participants of a UK primary-care based cardiovascular risk factor screening programme. BMC Public Health 5(1), 125 (2005).
13. Kurian A, Cardarelli K: Racial and ethnic differences in cardiovacular disease risk factors: a systematic review. Ethn. Dis. 17(1), 143-152 (2007).
14. Roberts H, Jiles R, Mokdad A, Beckles G, Rios-Burrows N: Trend analysis of diagnosed diabetes prevalence among American Indian/ Alaska native young adults-United States, 1994-2007. Ethn. Dis. 19, 276-279 (2009).
15. National Cholesterol Education Program: Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 17(25), 3143-3421 (2002).
16. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC: Hepatic lipase activity is lower in African-American men than in white American men: effects of 5́ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res. 39(1), 228-232 (1998).
17. Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC: Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 54(7), 902-909 (2005).
18. Utermann G: The mysteries of lipoprotein(a). Science 246(4932), 904 (1989).
19. Danesh J, Collins R, Peto R: Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 102(10), 1082-1085 (2000). (Pubitemid 30672833)
20. The Emerging Risk Factors C: Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302(4), 412-423 (2009).
21. Parra HJ, Luyeye I, Bouramoue C et al.: African-American-white differences in serum Lp(a) lipoprotein levels. Clin. Chem. Acta 168(1), 27-31 (1987).
22. Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H: Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J. Lipid Res. 37(12), 2569-2585 (1996).
23. Paultre F, Pearson TA, Weil HFC et al.: High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler. Thromb. Vasc. Biol. 20(12), 2619-2624 (2000).
24. Wu HD, Berglund L, Dimayuga C et al.: High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort. J. Am. Coll. Cardiol. 43(10), 1828-1833 (2004).
25. Tsimikas S, Clopton P, Brilakis ES et al.: Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study. Circulation 119(13), 1711-1719 (2009).
26. Robbins DC, Welty TK, Wang WY, Lee ET, Howard BV: Plasma lipids and lipoprotein concentrations among American Indians: comparison with the US population. Curr. Opin. Lipidol. 7(4), 188-195 (1996).
27. Welty TK, Lee ET, Yeh J et al.: Cardiovascular disease risk factors among American Indians: the Strong Heart Study. Am. J. Epidemiol. 142(3), 269-287 (1995).
28. Wang W, Hu D, Lee ET et al.: Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease: the Strong Heart Study. Ann. Epidemiol. 12(2), 107-114 (2002).
29. Gupta M, Singh N, Verma S: South Asians and cardiovascular risk: what clinicians should know. Circulation 113(25), E924-E929 (2006).
30. Karthikeyan G, Teo KK, Islam S et al.: Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART study. J. Am. Coll. Cardiol. 53(3), 244-253 (2009).
31. Geethanjali FS, Luthra K, Lingenhel A et al.: Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease. Atherosclerosis 169(1), 121-130 (2003).
32. Berglund L, Ramakrishnan R: Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler. Thromb. Vasc. Biol. 24(12), 2219-2226 (2004).
33. Hughes K, Aw TC, Kuperan P, Choo M: Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J. Epidemiol. Community Health 51(4), 394-399 (1997).
34. Keita SOY, Kittles RA, Royal CDM et al.: Conceptualizing human variation. Nat. Genet. 36(Suppl. 11), S17-S20 (2004).
35. Kittles RA, Weiss KM: Race, ancestry, and genes: implications for defining disease risk. Annu. Rev. Genomics Hum. Genet. 4(1), 33-67 (2003).
36. Peterson E, Yancy CW: Eliminating racial and ethnic disparities in cardiac care. N. Engl. J. Med. 360(12), 1172-1174 (2009).
37. Collins FS: What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era. Nat. Genet. 36(Suppl. 11), S13-S15 (2004).
38. Deo RC, Reich D, Tandon A et al.: Genetic Differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study. PLoS Genet. 5(1), E1000342 (2009).
39. Basu A, Tang H, Lewis CE et al.: Admixture mapping of quantitative trait loci for blood lipids in African-Americans. Hum. Mol. Genet. 18(11), 2091-2098 (2009).
40. Grundy SM, Cleeman JI, Daniels SR et al.: Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute scientific statement: executive summary. Circulation 112(17), E285-E290 (2005).
41. World Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. (1999).
42. Hoang KC, Le TV, Wong ND: The metabolic syndrome in East Asians. J. Cardiometab. Synd. 2(4), 276-282 (2007).
43. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 163(4), 427-436 (2003). (Pubitemid 36241019)
44. Stein E, Kushner H, Gidding S, Falkner B: Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metabolism 56(7), 954-960 (2007).
45. Sumner AE, Cowie CC: Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 196(2), 696-703 (2008).
46. Gaillard T, Schuster D, Osei K: Metabolic syndrome in black people of the African diaspora: the paradox of current classification, definition and criteria. Ethn. Dis. 19(Suppl. 2), S2-1-7 (2009).
47. Lea J, Greene E, Nicholas S, Agodoa L, Norris K: Cardiorenal metabolic syndrome in the African diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition. Ethn. Dis. 19(Suppl. 2), S2-11-14 (2009).
48. Churilla JR, Fitzhugh EC, Thompson DL: The metabolic syndrome: how definition impacts the prevalence and risk in US adults: 1999-2004 NHANES. Metab. Syndr. Relat. Disord. 5(4), 331-342 (2007).
49. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287(3), 356-359 (2002).
50. Paramsothy P, Knopp R, Bertoni AG, Tsai MY, Rue T, Heckbert SR: Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis. Metabolism 58(2), 212-219 (2009).
51. Russell M, De Simone G, Resnick HE, Howard BV: The metabolic syndrome in American Indians: the Strong Heart Study. J. Cardiometab. Synd. 2(4), 283-287 (2007).
52. Resnick HE, Jones K, Ruotolo G et al.: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. Diabetes Care 26(3), 861-867 (2003).
53. Alaupovic P, Blackett P, Wang W, Lee E: Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma Cherokee. J. Cardiometab. Synd. 3(4), 193-199 (2008).
54. Federation ID: Worldwide definition of the metabolic syndrome. (Ed.^(Eds) (Accessed June 20, 2009).
55. Bhalodkar NC, Blum S, Rana T et al.: Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am. J. Cardiol. 94(12), 1561-1563 (2004).
56. Obarzanek E, Sacks FM, Vollmer WM et al.: Effects on blood lipids of a blood pressurelowering diet: the Dietary Approaches to Stop Hypertension (DASH) trial. Am. J. Clin. Nutr. 74(1), 80-89 (2001). (Pubitemid 32574914)
57. Appel LJ, Sacks FM, Carey VJ et al.: Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294(19), 2455-2464 (2005).
58. Allen P, Thompson JL, Herman CJ et al.: Impact of periodic follow-up testing among urban American Indian women with impaired fasting glucose. Prev. Chronic Dis. 5(3), A76 (2008).
59. Haskell WL, Berra K, Arias E et al.: Multifactor cardiovascular disease risk reduction in medically underserved, high-risk patients. Am. J. Cardiol. 98(11), 1472-1479 (2006).
60. Sundquist J, Winkleby MA, Pudaric S: Cardiovascular disease risk factors among older Black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey 1994. J. Am. Geriatr. Soc. 49(2), 109-116 (2001).
61. Centers for Disease Control and Prevention: Trends in leisure-time physical inactivity by age, sex, and race/ethnicity-United States, 1994-2004. MMWR 54(39), 991-994 (2005).
62. Yurgalevitch SM, Kriska AM, Welty TK, Go O, Robbins DC, Howard BV: Physical activity and lipids and lipoproteins in American Indians ages 45-74. Med. Sci. Sports Exerc. 30(4), 543-549 (1998).
63. Balasubramanyam A, Rao S, Misra R, Sekhar R, Ballantyne C: Prevalence of metabolic syndrome and associated risk factors in Asian Indians. J. Immigr. Minor. Health, 10(4), 313-323 (2008).
64. Monda KL, Ballantyne CM, North KE: Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. J. Lipid Res. 50(8), 1685-1691 (2009).
65. Bhalodkar NC, Blum S, Rana T, Bhalodkar A, Kitchappa R, Enas EA: Effect of leisure time exercise on high-density lipoprotein cholesterol, its subclasses, and size in Asian Indians. Am. J. Cardiol. 96(1), 98-100 (2005).
66. Centers for Disease Control and Prevention: Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke-United States, 2003. JAMA 293(12), 1441-1443 (2005).
67. Lewis T, Everson-Rose S, Colvin A, Matthews K, Bromberger J, Sutton-Tyrell K: Interactive effects of race and depressive symptoms on calcification in African American and white women. Psychosom. Med. 71(2), 163-170 (2009).
68. Chichlowska KL, Rose KM, Diez-Roux AV, Golden SH, McNeill AM, Heiss G: Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) study. Psychosom. Med. 70(9), 986-992 (2008).
69. Merkin SS, Basurto-Dávila R, Karlamangla A et al.: Neighborhoods and cumulative biological risk profiles by race/ethnicity in a national sample of US adults: NHANES III. Ann. Epidemiol. 19(3), 194-201 (2009).
70. Osypuk TL, Diez Roux AV, Hadley C, Kandula NR: Are immigrant enclaves healthy places to live? The Multi-ethnic Study of Atherosclerosis. Soc. Sci. Med. 69(1), 110-120 (2009).
71. O'Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC: Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am. J. Cardiol. 85(8), 945-948 (2000).
72. Detrano R, Guerci AD, Carr JJ et al.: Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358(13), 1336-1345 (2008).
73. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ: Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228(3), 826-833 (2003).
74. Tang W, Detrano RC, Brezden OS et al.: Racial differences in coronary calcium prevalence among high-risk adults. Am. J. Cardiol. 75(16), 1088-1091 (1995).
75. Bild DE, Detrano R, Peterson D et al.: Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111(10), 1313-1320 (2005).
76. Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH: Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without Type 1 diabetes. Diabetes 51(6), 1949-1956 (2002).
77. Aiyer AN, Kip KE, Marroquin OC, Mulukutla SR, Edmundowicz D, Reis SE: Racial differences in coronary artery calcification are not attributed to differences in lipoprotein particle sizes: the Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) study. Am. Heart J. 153(2), 328-334 (2007).
78. Kronmal RA, McClelland RL, Detrano R et al.: Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 115(21), 2722-2730 (2007).
79. Budoff MJ, Nasir K, McClelland RL et al.: Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 53(4), 345-352 (2009).
80. Nasir K, Shaw LJ, Liu ST et al.: Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J. Am. Coll. Cardiol. 50(10), 953-960 (2007).
81. Krishnan P, Balamurugan A, Urbina E et al. Cardiovascular risk profile of asymptomatic healthy adults with increased carotid artery intima-media thickness: the Bogalusa Heart Study. J. LA State Med. Assoc. 155(3), 165-169 (2003).
82. Manolio T, Arnold A, Post W et al.: Ethnic differences in the relationship of carotid atherosclerosis to coronary calcification: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 197(1), 132-138 (2008).
83. Stein J, Korcarz C, Hurst R et al.: Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J. Am. Soc. Echocardiogr. 21(2), 93-111 (2008).
84. Khera A, McGuire DK, Murphy SA et al.: Race and gender differences in C-reactive protein levels. J. Am. Coll. Cardiol. 46(3), 464-469 (2005).
85. Lakoski SG, Cushman M, Criqui M et al.: Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am. Heart J. 152(3), 593-598 (2006). n A large epidemiologic study that notes the impact of gender on C-reactive protein despite important common confounders.
86. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am. J. Cardiol. 93(10), 1238-1242 (2004).
87. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A et al.: Ethnic differences in C-reactive protein concentrations. Clin. Chem. 54(6), 1027-1037 (2008).
88. Nazmi A, Victora C: Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 7(1), 212 (2007).
89. Anuurad E, Rubin J, Chiem A, Tracy RP, Pearson TA, Berglund L: High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. J. Clin. Endocrinol. Metab. 93(4), 1482-1488 (2008). n Original research noting a potential explanation for increased lipoprotein(a) in African-Americans, possibly related to levels of other inflammatory biomarkers.
90. Mann D, Reynolds K, Smith D, Muntner P: Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program Guidelines. Ann. Pharmacother. 42(9), 1208-1215 (2008).
91. Centers for Disease Control and Prevention: Disparities in screening for and awareness of high blood cholesterol-United States, 1999-2002. MMWR, 54(5), 117-119 (2005).
92. Clark LT, Maki KC, Galant R, Maron DJ, Pearson TA, Davidson MH: Ethnic differences in achievement of cholesterol treatment goals results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. JGIM 21(4), 320-326 (2006).
93. Simon JA, Lin F, Hulley SB et al.: Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) study. Am. J.Cardiol. 97(6), 843-850 (2006). n Original research article that identifies predictors of magnitude of response to simvastatin therapy in a biracial cohort.
94. Yood MU, McCarthy BD, Kempf J et al.: Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy. Am. Heart J. 152(4), 777-784 (2006).
95. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ: Relationship between quality of care and racial disparities in medicare health plans. JAMA 296(16), 1998-2004 (2006).
96. Brewster LM, Mairuhu G, Sturk A, van Montfrans GA: Distribution of creatine kinase in the general population: Implications for statin therapy. Am. Heart J. 154(4), 655-661 (2007).
97. Neal RC, Ferdinand KC, Ycas J, Miller E. Relationship of ethnic origin, gender, and age to blood creatine kinase levels. Am. J. Med. 122(1), 73-78 (2009).
98. Black HR, Quallich H, Gareleck CB: Racial differences in serum creatine kinase levels. Am. J. Med. 81(3), 479-487 (1986).
99. Thompson PD, Clarkson PM, Rosenson RS: An assessment of statin safety by muscle experts. Am. J. Cardiol. 97(8 Suppl. 1), S69-S76 (2006).
100. Ferdinand KC, Clark LT, Watson KE et al.: Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am. J. Cardiol. 97(2), 229-235 (2006).
101. Flack JM, Victor R, Watson K et al.: Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/ atorvastatin in African-Americans: the CAPABLE trial. Mayo Clin. Proc. 83(1), 35-45 (2008).
102. Lloret R, Ycas J, Stein M, Haffner S: Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial). Am. J. Cardiol. 98(6), 768-773 (2006). (Pubitemid 44301011)
103. Deedwania PC, Gupta M, Stein M, Ycas J, Gold A: Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS trial). Am. J. Cardiol. 99(11), 1538-1543 (2007).
104. Wu C, Sy R, Tanphaichitr V, Hin A, Suyono S, Lee Y: Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoproteincholesterol: a multinational, multicenter, double-blind study. J. Formos. Med. Assoc. 101(7), 478-487 (2002).
105. Howard BV, Roman MJ, Devereux RB et al.: Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 299(14), 1678-1689 (2008).
106. Ridker PM, Danielson E, Fonseca FAH et al.: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359(21), 2195-2207 (2008).
107. Krauss RM, Mangravite LM, Smith JD et al.: Variation in the 3-hydroxyl-3-methylglutaryl coenzyme A reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation 117(12), 1537-1544 (2008).
108. Gupta M, Braga MFB, Teoh H, Tsigoulis M, Verma S: Statin effects on LDL and HDL cholesterol in South Asian and white populations. J. Clin. Pharmacol. 49(7), 831-837 (2009).
109. Martin PD, Mitchell PD, Schneck DW: Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers. Br. J. Clin. Pharmacol. 54(5), 472-477 (2002).
110. Lee E, Ryan S, Birmingham B et al.: Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin. Pharmacol. Ther. 78(4), 330-341 (2005).
111. Ho R, Choi L, Lee W et al.: Effect of drug transporter genotypes on pravastatin disposition in European and African-American participants. Pharmacogenet. Genomics, 17(8), 647-656 (2007).
112. McPherson R, Frohlich J, Fodor G, Genest J: Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can. J. Cardiol. 22(11), 913-927 (2006).
113. Li X, Monda KL, Goring HHH et al.: Genome-wide linkage scan for plasma high density lipoprotein cholesterol, apolipoprotein A-1 and triglyceride variation among American Indian populations: The Strong Heart Family Study. J. Med. Genet. 46(7), 472-479 (2009).
114. Chen W, Li S, Srinivasan SR, Boerwinkle E, Berenson GS: A genome scan for loci influencing levels and trends of lipoprotein lipid-related traits since childhood: The Bogalusa Heart Study. Atherosclerosis 190(2), 248-255 (2007).
115. Malhotra A, Coon H, Feitosa MF et al.: Meta-analysis of genome-wide linkage studies for quantitative lipid traits in African Americans. Hum. Mol. Genet. 14(24), 3955-3962 (2005).
116. North KE, Goring HHH, Cole SA et al.: Linkage analysis of LDL cholesterol in American Indian populations: the Strong Heart Family Study. J. Lipid Res. 47(1), 59-66 (2006).
117. Pullinger CR, Aouizerat BE, Movsesyan I et al.: An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J. Lipid Res. 49(8), 1846-1854 (2008).
118. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW: A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum. Mol. Genet. 12(19), 2533-2539 (2003).
119. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC: Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet. 11(24), 3031-3038 (2002).
120. Chandak GR, Ward KJ, Yajnik CS et al.: Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med. Genet. 7(76) (2006).
121. Coletta DK, Schneider J, Hu SL et al.: Genome-wide linkage scan for genes influencing plasma triglyceride levels in the veterans administration genetic epidemiology study. Diabetes 58(1), 279-284 (2009).